The first application-specific module to be added to the new Streamline MP software suite is Refeyn’s Antibody Stability Module, which automatically characterizes aggregation in large batches of ...
Prothena's antibody targets an area within the microtubule ... trial in early-stage Alzheimer's last year, and TauRx' tau aggregation inhibitor LMTX which wasn't able to improve on placebo in ...
Lundbeck initiates a phase III trial with amlenetug for the treatment of Multiple System AtrophyMASCOT, a global phase III randomized, double-blind, placebo-controlled trial, will assess the efficacy ...